![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Dresden University of Technology |
Information provided by: | Dresden University of Technology |
ClinicalTrials.gov Identifier: | NCT00153998 |
General Objectives:
Condition | Intervention | Phase |
Colorectal Cancer Liver Metastases |
Drug: Cetuximab Procedure: Liver resection |
Phase II |
MedlinePlus related topics: | Cancer Colorectal Cancer |
ChemIDplus related topics: | Irinotecan Irinotecan hydrochloride Fluorouracil Oxaliplatin Cetuximab |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study |
Official Title: | Open, Randomized, Multicenter, Randomized Phase II Trial Comparing the Combination of Cetuximab With Oxaliplatin/5-FU/FA Versus the Combination of Cetuximab With Irinotecan/5-FU/FA as Neoadjuvant Treatment in Patients With Non-Resectable Colorectal Liver Metastases |
Estimated Enrollment: | 135 |
Study Start Date: | November 2004 |
Patients with liver metastasis will be screened for this study. Eligible patients will complete the pretreatment evaluation including an abdominal CT scan that will be presented to the local surgeon and the radiologist for proving of resectability of hepatic lesions. Additionally, CT scans will be reviewed by three reference surgeons. In case of non-resectability, as defined above, CT- or ultrasound- guided biopsy of one of the liver metastases will be performed, unless biopsy material is available from prior biopsy of one of the liver metastases.
Instead of an ultrasound-guided biopsy, a CT-guided biopsy may be performed.
Formalin-fixed, paraffin embedded metastatic tissue will be sent to reference laboratory (Prof. Störkel, Wuppertal) for immunohistochemical analysis of EGFR- expression.
Additionally tissue will be stored in "RNA later" for gene expression analysis if agreed by the patient.
Additionally, the primary tumor will be collected and sent to the reference laboratory for analysis of EGFR- expression (if agreement of the patient exists).
Patients will be randomized to a combination of:
Cetuximab/FOLFIRI (irinotecan/5-FU/FA) or Cetuximab/FOLFOX6 (oxaliplatin/5-FU/FA)
All patients receive a four month treatment (eight cycles) of the allocated treatment.
Resection is planned after completion of neoadjuvant treatment and should be performed between 4 and 6 weeks after the last dose of chemotherapy. Probes of the resected material (in liquid nitrogen and paraffin embedded material will be collected).
If a resection is not possible after eight administrations of chemotherapy, chemotherapy will be continued until tumor progression (maximal duration of treatment 2 years) and the patient will be evaluated for a potential resection every two months.
After resection, postoperative treatment is planned for 3 months (6 cycles). Treatment start is planned between 4 and 8 weeks after the operation.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Claus-Henning Köhne, Prof. Dr. | +49 441 403 2611 | onkologie@klinikum-oldenburg.de |
Contact: Gunnar Folprecht, Dr. med. | +49 351 458 4794 | gunnar.folprecht@uniklinikum-dresden.de |
Austria | |||||
Medizinische Universitaet Wien, Universitaetsklinik für Chirurgie | Recruiting | ||||
Wien, Austria, A-1090 | |||||
Contact: Thomas Gruenberger, Prof. thomas.gruenberger@univie.ac.at | |||||
Principal Investigator: Thomas Gruenberger, Prof. | |||||
Germany | |||||
University Hospital "Carl Gustav Carus" | Recruiting | ||||
Dresden, Germany, 01307 | |||||
Contact: Gunnar Folprecht, Dr +49 351 458 4794 gunnar.folprecht@uniklinikum-dresden.de | |||||
Principal Investigator: Gunnar Folprecht, Dr | |||||
Klinikum Oldenburg GmbH | Recruiting | ||||
Oldenburg, Germany, 26133 | |||||
Contact: Claus-Henning Köhne, Prof. Dr. +49 441 403-2610 onkologie@klinikum-oldenburg.de | |||||
Principal Investigator: Claus-Henning Köhne, Prof. | |||||
Universitaetsklinikum Tuebingen | Recruiting | ||||
Tuebingen, Germany, 72076 | |||||
Contact: Joerg T. Hartmann, PD +49 7071/298 2127 /2125 joerg.hartmann@med.uni-tuebingen.de | |||||
Principal Investigator: Joerg T. Hartmann, PD | |||||
Krankenhaus der Barmherzigen Brueder Trier, Chirurgie | Recruiting | ||||
Trier, Germany, 54292 | |||||
Contact: Detlef-Martin Ockert, PD | |||||
Principal Investigator: Detlef-Martin Ockert, PD | |||||
Johann Wolfgang Goethe Universitaet, Chirurgie | Recruiting | ||||
Frankfurt Main, Germany, 60596 | |||||
Contact: Wolf Bechstein, Prof. +49 69/ 6301 5251 wolf.bechstein@kgu.de | |||||
Principal Investigator: Wolf Bechstein, Prof. | |||||
Universitaetsklinikum Wuerzburg, Chirurgie | Recruiting | ||||
Wuerzburg, Germany, 97080 | |||||
Contact: Meyer, PD | |||||
Principal Investigator: Meyer, PD | |||||
Universitaet Erlangen-Nuernberg, Chirurgie | Not yet recruiting | ||||
Erlangen, Germany, 91054 | |||||
Contact: Werner Hohenberger, Prof. +49 9131-853-3201 sekretariat@chir.imed.uni-erlangen.de | |||||
Principal Investigator: Werner Hohenberger, Prof. | |||||
Westdeutsches Tumorzentrum, Universitaetsklinikum Essen | Not yet recruiting | ||||
Essen, Germany, 45112 | |||||
Contact: Tanja Trarbach, Dr. +49 201/723-2039 tanja.trarbach@uni-essen.de | |||||
Principal Investigator: Tanja Trarbach, Dr. | |||||
Staedtisches Klinikum Magdeburg-Olvenstedt | Recruiting | ||||
Magdeburg, Germany, 39130 | |||||
Contact: Karsten Ridwelski, PD +49 391/791 4201 Karsten.Ridwelski@Klinikum-Magdeburg.de | |||||
Principal Investigator: Karsten Ridwelski, PD | |||||
Allgemeines Krankenhaus Celle | Recruiting | ||||
Celle, Germany, 29223 | |||||
Contact: Stephan Hollerbach, PD + 49 5141/ 721200 stephan.hollerbach@akh-celle.de | |||||
Principal Investigator: Stephan Hollerbach, PD | |||||
Klinikum Passau, II. Medizinische Klinik | Not yet recruiting | ||||
Passau, Germany, 94032 | |||||
Contact: Thomas Suedhoff, PD | |||||
Principal Investigator: Thomas Suedhoff, PD | |||||
Klinikum der Hansestadt Stralsund GmbH, Medizinische Klinik | Not yet recruiting | ||||
Stralsund, Germany, 18435 | |||||
Contact: T. H. Ittel, Prof. +49 3831-352700 ittel@klinikum-stralsund.de | |||||
Principal Investigator: T. H. Ittel, Prof. | |||||
Kreiskrankenhaus Aschersleben | Recruiting | ||||
Aschersleben, Germany, 06449 | |||||
Contact: Tillmann Deist, Dr. | |||||
Principal Investigator: Tillmann Deist, Dr. | |||||
Klinikum Grosshadern, III. Medizinische Klinik | Not yet recruiting | ||||
Muenchen, Germany, 81377 | |||||
Contact: Volker Heinemann, Prof. volker.heinemann@med3.med.uni-muenchen.de | |||||
Principal Investigator: Volker Heinemann, Prof. | |||||
UKSH Campus Kiel, II. Medizinische Klinik | Not yet recruiting | ||||
Kiel, Germany, 24116 | |||||
Contact: Michael Kneba, Prof. +49 431/1697-1200 m.kneba@med2.uni-kiel.de | |||||
Principal Investigator: Michael Kneba, Prof. | |||||
Universitaetsklinik Mannheim gGmbH, III. Medizinische Klinik | Not yet recruiting | ||||
Mannheim, Germany, 68167 | |||||
Contact: Ralf-Dieter Hofheinz, Dr. +49 621/3832762 o. 2855 ralf.hofheinz@med3.ma.uni-heidelberg.de | |||||
Principal Investigator: Ralf-Dieter Hofheinz, Dr. | |||||
Westpfalz-Klinikum GmbH Innere Medizin I | Not yet recruiting | ||||
Kaiserslautern, Germany, 67653 | |||||
Contact: Hartmut Link, Prof. +49 631/203-1669 oder -1260 Hlink@rhrk.uni-kl.de | |||||
Principal Investigator: Hartmut Link, Prof. | |||||
Florence-Nightingale-Krankenhaus | Not yet recruiting | ||||
Duesseldorf, Germany, 40489 | |||||
Contact: Erckenbrecht, Prof. | |||||
Principal Investigator: Erckenbrecht, Prof. | |||||
Charite-Campus Benjamin Franklin, Innere Medizin | Not yet recruiting | ||||
Berlin, Germany, 12200 | |||||
Contact: Ulrich Keilholz, Prof. +49 30/8445-3906 keilholz@ukbf.fu-berlin.de | |||||
Principal Investigator: Ulrich Keilholz, Prof. | |||||
Charite-Campus, Virchow-Klinikum, Innere Medizin | Not yet recruiting | ||||
Berlin, Germany, 13353 | |||||
Contact: Hanno Riess, Prof. +49 30-450-553013 hanno.riess@charite.de | |||||
Principal Investigator: Hanno Riess, Prof. | |||||
Germany, Bayern | |||||
Klinikum Rechts der Isar, III. Medizinische Klinik | Recruiting | ||||
Muenchen, Bayern, Germany, 81675 | |||||
Contact: Florian Lordick, PD + 49 89/ 4140 6628 f.lordick@lrz.tum.de | |||||
Principal Investigator: Florian Lordick, PD |
Dresden University of Technology |
Principal Investigator: | Claus-Henning Köhne, Prof. Dr. | Klinikum Oldenburg GmbH, Dr.-Eden-Str.10; 26133 Oldenburg |
Principal Investigator: | Gunnar Folprecht, Dr. | University Hospital Dresden, Fetscherstr. 74, 01307 Dresden, Germany |
Study ID Numbers: | CELIM |
First Received: | September 8, 2005 |
Last Updated: | July 27, 2007 |
ClinicalTrials.gov Identifier: | NCT00153998 |
Health Authority: | Germany: Paul-Ehrlich-Institut |
|
|
|
|
|
|
![]() |